Discontinuation report EMCYT
Report ID | 98547 |
Drug Identification Number | 02063794 |
Brand name | EMCYT |
Common or Proper name | EMCYT |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ESTRAMUSTINE PHOSPHATE SODIUM |
Strength(s) | 140MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-11-07 |
Remaining supply date | 2020-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Inventory will be available for distribution until February 28, 2020 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-12 | English | Compare |
v2 | 2019-11-12 | French | Compare |
Showing 1 to 2 of 2